Vilnius, Lithuania

Donata Ulcinaite


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Spotlight: Donata Ulcinaite

Introduction

Donata Ulcinaite is an accomplished inventor based in Vilnius, Lithuania, recognized for her contributions to biotechnology. Her notable work focuses on the development of antibodies that have significant implications in molecular biology and genetics.

Latest Patents

Ulcinaite holds a patent concerning antibodies that bind thermophilic DNA polymerases. This patent involves antibodies that interact specifically with family B DNA polymerases, which are vital for various applications in DNA amplification and molecular diagnostics. The detailed disclosure includes related uses, methods, and compositions that pave the way for advancements in the field.

Career Highlights

Currently, Ulcinaite is part of Thermo Fisher Scientific Baltics UAB, a leading organization in scientific research and manufacturing. Her work enhances the capabilities of the company to deliver innovative solutions in life sciences. The impact of her inventions extends beyond her immediate work environment, contributing to a wider array of scientific and industrial applications.

Collaborations

While working at Thermo Fisher Scientific Baltics UAB, Ulcinaite collaborates with esteemed colleagues such as Renata Rimseliene and Birute Gagiliene. These collaborations are essential for driving research initiatives and developing breakthrough technologies that can transform current practices in biotechnology.

Conclusion

Donata Ulcinaite's contributions to the field of biotechnology exemplify the importance of innovation in scientific research. Her patent on antibodies that bind thermophilic DNA polymerases showcases her skills as an inventor and emphasizes the critical role of collaboration in advancing technology. As she continues her journey in research and innovation, she remains a valuable asset to both her company and the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…